TWAPF
vs
S&P 500
TWAPF
S&P 500
Over the past 12 months, TWAPF has underperformed S&P 500, delivering a return of -34% compared to the S&P 500's +33% growth.
Stocks Performance
TWAPF vs S&P 500
Performance Gap
TWAPF vs S&P 500
Performance By Year
TWAPF vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Towa Pharmaceutical Co Ltd
Glance View
Towa Pharmaceutical Co., Ltd. engages in the manufacture and distribution of pharmaceutical products. The company is headquartered in Kadoma-Shi, Osaka-Fu and currently employs 3,456 full-time employees. The company went IPO on 2004-04-05. The main products are generic drugs, which are launched after the efficacy and safety of new drugs have been confirmed for a certain period of time. The company is a drug with the same effect, usage and dosage. The firm is involved in the sale and outsourced manufacture of products and generic drugs. The firm is involved in the research and outsourced manufacture of active pharmaceutical ingredient and soft capsules. The firm is also involved in the planning, development, contract manufacturing of health foods, general foods, miscellaneous goods and others.
